[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100655093":3},{"organization":4,"outcomesModule":7,"designInfo":34,"detailedDescription":18,"studyPopulation":18,"armGroups":40,"interventions":54,"overallOfficials":18,"centralContacts":67,"locations":73,"responsibleParty":100,"collaborators":102,"id":117,"slug":118,"hasResults":119,"nctId":120,"briefTitle":121,"officialTitle":121,"acronym":122,"eligibilityCriteria":123,"healthyVolunteers":119,"sex":124,"minAge":125,"maxAge":18,"enrollmentInfo":126,"targetDuration":18,"studyType":129,"phases":130,"briefSummary":132,"conditions":133,"keywords":138,"overallStatus":143,"whyStopped":18,"lastUpdateSubmitDate":144,"lastUpdatePostDateStruct":145,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":153},{"fullName":5,"class":6},"Centre Hospitalier Universitaire, Amiens","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":15,"otherOutcomes":18},[9,13],{"measure":10,"description":11,"timeFrame":12},"change in anxiety score obtained using the STAI-Y State scale","The State-Trait Anxiety Inventory (STAI), specifically Form Y (STAI-Y), stands as one of the most widely utilized self-report measures in psychological and medical research for the quantitative assessment of anxiety.\n\nThe STAI-Y operationalizes the psychological construct of anxiety as having two independent dimensions, each measured by 20 items for a total of 40 items in the complete inventory.\n\nState Anxiety (A-State) is defined as a transient emotional response characterized by immediate, subjective feelings of tension, apprehension, worry, and physiological activation of the autonomic nervous system. Respondents assess their feelings \"right now, at this moment\" using a 4-point intensity scale. In contrast, Trait Anxiety (A-Trait) refers to stable individual differences in anxiety proneness. Individuals scoring high in A-Trait are predisposed to perceive a broader range of situations as threatening and are likely to react to these situations with elevated A-State responses. A-Trait","1 week",{"measure":10,"description":11,"timeFrame":14},"2 weeks",[16,20,22,24,26,28,30,31,32,33],{"measure":17,"description":18,"timeFrame":19},"PANAS questionnaire (Positive and Negative Affect Scale)",null,"30 minutes after the session",{"measure":21,"description":18,"timeFrame":19},"Variations in scores of the STAI-Y ETAT scale",{"measure":23,"description":18,"timeFrame":19},"pulse variation",{"measure":25,"description":18,"timeFrame":19},"BP variation",{"measure":27,"description":18,"timeFrame":19},"respiratory rate",{"measure":17,"description":18,"timeFrame":29},"one week after the 6th session",{"measure":21,"description":18,"timeFrame":29},{"measure":23,"description":18,"timeFrame":29},{"measure":25,"description":18,"timeFrame":29},{"measure":27,"description":18,"timeFrame":29},{"allocation":35,"interventionModel":36,"interventionModelDescription":18,"primaryPurpose":37,"observationalModel":18,"timePerspective":18,"maskingInfo":38},"RANDOMIZED","PARALLEL","SUPPORTIVE_CARE",{"masking":39,"maskingDescription":18,"whoMasked":18},"NONE",[41,48],{"label":42,"type":43,"description":44,"interventionNames":45},"Group without music therapy","ACTIVE_COMPARATOR","* Management of anxiety, pain, and depression according to the usual pharmacological and non-pharmacological practices of each center.\n* Assessment of PANAS questionnaire, TSAI test, digital scale measurement, physiological constants (pulse, blood pressure, respiratory rate) 3 times a week for 2 weeks, then 7 days after the last of these 6 assessments.\n* Evaluation of quality of life at last assessment",[46,47],"Other: depression management","Other: questionnaire",{"label":49,"type":50,"description":51,"interventionNames":52},"Music therapy group","EXPERIMENTAL","* Management of anxiety, pain, and depression according to the usual pharmacological and non-pharmacological practices of each center.\n* Six 30-minute sessions of receptive ISM with Kigonki according to study protocol\n* Assessment of the PANAS questionnaire, TSAI test, digital scale measurement, physiological constants (pulse, blood pressure, respiratory rate) 3 times a week for 2 weeks, then 7 days after the last of these 6 assessments.\n\nTri-weekly assessments will be repeated 30 minutes after each ISM session.\n\n\\- Evaluation of quality of life at last assessment",[46,53,47],"Other: Kigonki",[55,59,63],{"type":6,"name":56,"description":57,"armGroupLabels":58,"otherNames":18},"depression management","\\- Management of anxiety, pain, and depression according to the usual pharmacological and non-pharmacological practices of each center.",[42,49],{"type":6,"name":60,"description":61,"armGroupLabels":62,"otherNames":18},"Kigonki","Six 30-minute sessions of receptive ISM with Kigonki according to study protocol",[49],{"type":6,"name":64,"description":65,"armGroupLabels":66,"otherNames":18},"questionnaire","Assessment of PANAS questionnaire, TSAI test, digital scale measurement, physiological constants (pulse, blood pressure, respiratory rate) 3 times a week for 2 weeks, then 7 days after the last of these 6 assessments.",[42,49],[68],{"name":69,"role":70,"phone":71,"phoneExt":18,"email":72},"Julie Oncle, MD","CONTACT","33+03 22 45 64 43","Oncle.julie@chu-amiens.fr",[74],{"facility":75,"status":18,"city":76,"state":18,"zip":77,"country":78,"countryCode":79,"cosmosGeoPoint":80,"geoPoint":85,"contacts":86},"CHRU Amiens","Amiens","80480","France","FR",{"type":81,"coordinates":82},"Point",[83,84],2.3,49.9,{"lat":84,"lon":83},[87,90,92,94,96,98],{"name":88,"role":89,"phone":18,"phoneExt":18,"email":18},"Brassaint, MD","PRINCIPAL_INVESTIGATOR",{"name":91,"role":89,"phone":18,"phoneExt":18,"email":18},"Anne VANBESIEN, MD",{"name":93,"role":89,"phone":18,"phoneExt":18,"email":18},"Sophie RIVENQ, MD",{"name":95,"role":89,"phone":18,"phoneExt":18,"email":18},"Isabelle QUENTIN, MD",{"name":97,"role":89,"phone":18,"phoneExt":18,"email":18},"Laurence BIRKUI, MD",{"name":99,"role":89,"phone":18,"phoneExt":18,"email":18},"MEROT, MD",{"type":101,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[103,106,108,111,113,115],{"name":104,"class":105},"Centre Hospitalier de Bethune","NETWORK",{"name":107,"class":6},"Centre Hospitalier de Douai",{"name":109,"class":110},"Hospital of Lens","UNKNOWN",{"name":112,"class":110},"GHPSO site de Senlis",{"name":114,"class":110},"CH de Compiegne",{"name":116,"class":6},"Centre Hospitalier de Beauvais","100655093","evaluation-of-the-effectiveness-of-music-therapy-on-anxiety-levels-in-patients-with-advanced-cancer-hospitalized-in-a-palliative-care-unit-100655093",false,"NCT07806435","Evaluation of the Effectiveness of Music Therapy on Anxiety Levels in Patients With Advanced Cancer Hospitalized in a Palliative Care Unit","CessataEl'ansi","Inclusion Criteria:\n\n* Age \\> 18 years\n* Patient hospitalized in palliative care unit for oncological pathology\n* Presenting an anxiety score \\> 46 (according to the STAI-Y State scale)\n* Whose subsequent hospitalization is estimated to last more than three weeks\n* No deafness likely to interfere with a receptive music therapy session (no difficulty in understanding whispered speech).\n* Affiliated with a social security scheme\n* Have signed the consent form for the study\n\nExclusion Criteria:\n\n* Deafness without hearing aids\n* Patients under guardianship, curatorship or safeguard of justice\n* Pregnant or breast-feeding\n* Not affiliated to a social security scheme\n* Patient with an aversion to the sounds produced by the Kigonki","ALL","18 Years",{"count":127,"type":128},84,"ESTIMATED","INTERVENTIONAL",[131],"NA","A music therapy intervention can be either receptive or active. In both cases, somatic effects have been observed, with a direct impact on respiratory, cardiac and hemodynamic parameters, as well as psychological effects, creating a relationship of support, accompaniment and listening to the person. An intervention protocol using Kigonki has been developed and validated by the University Diploma in Music Therapy team at Paul-Valéry Montpellier 3 University (DUMM3). Studies on music therapy in palliative care have been published, but there is still a need for large controlled studies assessing the prolonged effect of a standardized intervention. This randomized clinical is designed for patients with terminal cancer pathology, hospitalized in palliative care units and with anxiety and depression scores both above 11 on the Hospital Anxiety and Depression scale (HAD). The primary endpoint is change in anxiety score. Patients included in the experimental arm will be offered the above-mentioned protocol with 3 weekly sessions of receptive music therapy with Kigonki for 2 weeks, after drawing up an intervention plan. Anxiety\u002Fdepression levels will be measured before and 30 minutes after each session, as well as one week after the last session. Patients in the reference arm will have their anxiety\u002Fdepression level monitored 3 times a week. In both arms, the study will be terminated at the end of the last protocol evaluation (i.e., at 3 weeks). If anxiety worsens (score rises by 2 points), a music therapy intervention similar to that performed for patients of the experimental arm may be proposed to patients of the reference arm. This project requires the participation of 84 patients, which seems feasible at the inter-regional level in 7 centers over 18 months.",[134,135,136,137],"Music Therapy","Palliative Care","Cancer","Anxiety",[139,140,141,142],"anxiety","Music therapy","palliative care","cancer","NOT_YET_RECRUITING","2026-09-03",{"date":146,"type":147},"2026-09-08","ACTUAL",{"date":149,"type":128},"2026-10",{"date":151,"type":128},"2028-04",{"name":5,"class":6},1]